XML 62 R47.htm IDEA: XBRL DOCUMENT v3.22.4
Business Combination - Intangible Assets Acquired (Details) - Antares Pharma, Inc - USD ($)
$ in Thousands
7 Months Ended
Dec. 31, 2022
May 24, 2022
Business Acquisition [Line Items]    
TLANDO product rights $ 589,800 $ 987,500
ATRS-1902 (IPR&D)    
Business Acquisition [Line Items]    
Indefinite-lived intangible assets acquired 48,700  
Auto-Injector technology platform    
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired $ 402,000  
Useful life (years) 7 years  
XYOSTED proprietary product    
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired $ 136,200  
Useful life (years) 10 years  
TLANDO product rights    
Business Acquisition [Line Items]    
Finite-lived intangible assets acquired $ 2,900  
Useful life (years) 10 years